顯示所有 16 筆結果
-
Anti-IL-2R [Daclizumab] (Ab00187-1.1-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-1.1)
-
Anti-IL-2R [Daclizumab] (Ab00187-10.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-10.0)
-
Anti-IL-2R [Daclizumab] (Ab00187-10.3-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-10.3)
-
Anti-IL-2R [Daclizumab] (Ab00187-2.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-2.0)
-
Anti-IL-2R [Daclizumab] (Ab00187-2.3-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-2.3)
-
Anti-IL-2R [Daclizumab] (Ab00187-23.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-23.0)
-
Anti-IL-2R [Daclizumab] (Ab00187-26.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-26.0)
-
Anti-IL-2R [Daclizumab] (Ab00187-35.0-BT)
-
Anti-IL-2R [Daclizumab] (Ab00187-35.0)